Asciminib Chronic Phase Chronic Myeloid Leukemia: A Real-World Single Institution Case SeriesSeptember 10, 2023Hematologic MalignanciesOncology
Rasburicase Use and Glucose-6-Phosphate Dehydrogenase TestingSeptember 10, 2023CancerHematologic Malignancies
Comparing Outcomes and Toxicities With Standard and Reduced Dose Melphalan in Autologous Stem Cell Transplant Patients With Multiple MyelomaSeptember 10, 2023Multiple MyelomaHematologic MalignanciesOncology
Cancer Patients: Who’s at Risk for Venous Thromboembolism?July 24, 2023Hematologic MalignanciesWomen's HealthGenitourinary Cancer
Ibrutinib + venetoclax: High-risk features don’t lessen CLL responseJune 15, 2023Hematologic Malignancies
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Lung CancerBreast CancerGenitourinary CancerMixed TopicsMelanomaAMLBusiness of Medicine
Cross-border U.S.-Mexican collaboration drives up ALL survivalJune 4, 2023Diversity in MedicineHematologic Malignancies
